US Bancorp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.2M | Buy |
275,250
+23,563
| +9% | +$1.01M | 0.01% | 388 |
|
|
2026
Q1 | $9.25M | Buy |
251,687
+27,274
| +12% | +$1.29M | 0.01% | 431 |
|
|
2025
Q4 | $11.4M | Sell |
224,413
-44,950
| -17% | -$2.3M | 0.01% | 406 |
|
|
2025
Q3 | $14.9M | Sell |
269,363
-30,103
| -10% | -$1.76M | 0.02% | 368 |
|
|
2025
Q2 | $20.7M | Sell |
299,466
-39,004
| -12% | -$2.65M | 0.03% | 317 |
|
|
2025
Q1 | $23.5M | Buy |
338,470
+3,493
| +1% | +$288K | 0.03% | 292 |
|
|
2024
Q4 | $28.8M | Sell |
334,977
-31,858
| -9% | -$3.45M | 0.04% | 262 |
|
|
2024
Q3 | $43.7M | Buy |
366,835
+231
| +0.1% | +$30.8K | 0.06% | 211 |
|
|
2024
Q2 | $52.3M | Sell |
366,604
-27,578
| -7% | -$3.65M | 0.07% | 184 |
|
|
2024
Q1 | $50.6M | Sell |
394,182
-11,488
| -3% | -$1.37M | 0.07% | 187 |
|
|
2023
Q4 | $42M | Buy |
405,670
+11,729
| +3% | +$1.16M | 0.06% | 198 |
|
|
2023
Q3 | $35.8M | Sell |
393,941
-1,729
| -0.4% | -$152K | 0.06% | 208 |
|
|
2023
Q2 | $32M | Buy |
395,670
+27,862
| +8% | +$2.28M | 0.05% | 226 |
|
|
2023
Q1 | $29.3M | Buy |
367,808
+41,530
| +13% | +$2.94M | 0.05% | 238 |
|
|
2022
Q4 | $22.1M | Sell |
326,278
-12,742
| -4% | -$747K | 0.04% | 272 |
|
|
2022
Q3 | $16.9M | Buy |
339,020
+1,624
| +0.5% | +$87K | 0.03% | 279 |
|
|
2022
Q2 | $18.8M | Buy |
337,396
+3,978
| +1% | +$221K | 0.04% | 281 |
|
|
2022
Q1 | $18.5M | Sell |
333,418
-24,102
| -7% | -$1.24M | 0.03% | 313 |
|
|
2021
Q4 | $20M | Buy |
357,520
+57,320
| +19% | +$3.11M | 0.03% | 300 |
|
|
2021
Q3 | $14.4M | Buy |
300,200
+38,174
| +15% | +$1.85M | 0.03% | 331 |
|
|
2021
Q2 | $11M | Sell |
262,026
-2,332
| -0.9% | -$90.4K | 0.02% | 383 |
|
|
2021
Q1 | $8.91M | Sell |
264,358
-38,872
| -13% | -$1.38M | 0.02% | 421 |
|
|
2020
Q4 | $10.6M | Sell |
303,230
-8,650
| -3% | -$299K | 0.02% | 367 |
|
|
2020
Q3 | $10.8M | Buy |
311,880
+32,776
| +12% | +$1.09M | 0.03% | 346 |
|
|
2020
Q2 | $9.14M | Sell |
279,104
-1,858
| -0.7% | -$59.3K | 0.02% | 370 |
|
|
2020
Q1 | $8.46M | Sell |
280,962
-97,864
| -26% | -$2.91M | 0.03% | 348 |
|
|
2019
Q4 | $11M | Sell |
378,826
-23,850
| -6% | -$660K | 0.03% | 350 |
|
|
2019
Q3 | $10.4M | Sell |
402,676
-54,648
| -12% | -$1.38M | 0.03% | 353 |
|
|
2019
Q2 | $11.7M | Sell |
457,324
-152,242
| -25% | -$3.76M | 0.03% | 342 |
|
|
2019
Q1 | $15.9M | Sell |
609,566
-484
| -0.1% | -$11.9K | 0.05% | 285 |
|
|
2018
Q4 | $14.1M | Buy |
610,050
+83,572
| +16% | +$1.86M | 0.05% | 282 |
|
|
2018
Q3 | $12.4M | Sell |
526,478
-9,168
| -2% | -$224K | 0.04% | 325 |
|
|
2018
Q2 | $12.4M | Buy |
535,646
+76,330
| +17% | +$1.81M | 0.04% | 312 |
|
|
2018
Q1 | $11.3M | Sell |
459,316
-6,830
| -1% | -$179K | 0.03% | 332 |
|
|
2017
Q4 | $12.5M | Buy |
466,146
+12,240
| +3% | +$311K | 0.04% | 312 |
|
|
2017
Q3 | $10.9M | Buy |
453,906
+23,426
| +5% | +$529K | 0.04% | 328 |
|
|
2017
Q2 | $9.23M | Sell |
430,480
-7,918
| -2% | -$160K | 0.03% | 353 |
|
|
2017
Q1 | $7.51M | Buy |
438,398
+43,186
| +11% | +$752K | 0.03% | 394 |
|
|
2016
Q4 | $7.09M | Sell |
395,212
-65,082
| -14% | -$1.18M | 0.03% | 398 |
|
|
2016
Q3 | $9.57M | Sell |
460,294
-6,298
| -1% | -$156K | 0.04% | 335 |
|
|
2016
Q2 | $12.5M | Sell |
466,592
-49,936
| -10% | -$1.37M | 0.05% | 296 |
|
|
2016
Q1 | $14M | Sell |
516,528
-214,490
| -29% | -$5.75M | 0.06% | 266 |
|
|
2015
Q4 | $21.2M | Sell |
731,018
-98,556
| -12% | -$2.73M | 0.09% | 197 |
|
|
2015
Q3 | $22.5M | Sell |
829,574
-8,612
| -1% | -$244K | 0.09% | 187 |
|
|
2015
Q2 | $22.9M | Buy |
838,186
+49,154
| +6% | +$1.38M | 0.09% | 201 |
|
|
2015
Q1 | $21.1M | Buy |
789,032
+15,296
| +2% | +$352K | 0.08% | 215 |
|
|
2014
Q4 | $16.4M | Buy |
773,736
+12,454
| +2% | +$278K | 0.06% | 248 |
|
|
2014
Q3 | $18.1M | Buy |
761,282
+40,090
| +6% | +$923K | 0.07% | 215 |
|
|
2014
Q2 | $16.7M | Buy |
721,192
+8,522
| +1% | +$188K | 0.07% | 230 |
|
|
2014
Q1 | $16.3M | Buy |
712,670
+34,470
| +5% | +$734K | 0.07% | 227 |
|
|
2013
Q4 | $12.5M | Buy |
678,200
+52,240
| +8% | +$910K | 0.05% | 270 |
|
|
2013
Q3 | $10.6M | Buy |
625,960
+21,150
| +3% | +$356K | 0.05% | 278 |
|
|
2013
Q2 | $9.37M | Buy |
+604,810
| New | +$10.1M | 0.04% | 303 |
|
Other funds holding NVO
F
US Bancorp's NVO Position: Q2 2026 in Review
US Bancorp increased its Novo Nordisk (NVO) stake by 9.4% in Q2 2026, buying an estimated $1.01M and bringing the position to 275,250 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #388.
US Bancorp first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.3M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- US Bancorp held 275,250 shares of Novo Nordisk worth $13.2M as of Q2 2026.
- US Bancorp bought 23,563 Novo Nordisk shares in Q2 2026, an estimated $1.01M.
- Novo Nordisk made up 0.01% of US Bancorp's portfolio in Q2 2026, its #388 holding.
- US Bancorp first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Novo Nordisk position peaked at $52.3M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.